Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.720
-0.050 (-2.82%)
Jun 3, 2026, 12:21 PM EDT - Market open
Propanc Biopharma Employees
As of June 30, 2025, Propanc Biopharma had 2 total employees, including 1 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$9,646,588
Market Cap
1.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 2 | 0 | - | 1 | 1 |
| Jun 30, 2024 | 2 | 0 | - | 1 | 1 |
| Jun 30, 2023 | 2 | -1 | -33.33% | 1 | 1 |
| Jun 30, 2022 | 3 | 1 | 50.00% | 1 | 2 |
| Jun 30, 2021 | 2 | -1 | -33.33% | 1 | 1 |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 45 |
| Calidi Biotherapeutics | 29 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Ensysce Biosciences | 10 |
| Artelo Biosciences | 7 |
PPCB News
- 1 day ago - Propanc Biopharma's CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain - GlobeNewsWire
- 14 days ago - Propanc Biopharma's CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade - GlobeNewsWire
- 15 days ago - Propanc Biopharma engages European CDMO for GMP production of PRP - TheFly
- 15 days ago - Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients - GlobeNewsWire
- 18 days ago - Propanc Biopharma Inc trading halted, news pending - TheFly
- 19 days ago - Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results - GlobeNewsWire
- 20 days ago - Propanc Biopharma announces 1-for-25 reverse stock split - TheFly
- 20 days ago - Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans - GlobeNewsWire